Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Data by

Global Data

9

Revenue 2014

Gilead Sciences

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Gilead Sciences' 2013 sales performance.

Medicxi aims to plug funding gap for European biotech

Medicxi aims to plug funding gap for European biotech

like US companies Amgen, Genentech or Gilead - all too often promising projects and innovation leak away to other regions.

ViiV files two-drug HIV maintenance regimen

ViiV files two-drug HIV maintenance regimen to bring the new combination to market ahead of a new triplet regimen from Gilead Sciences, its fiercest competitor in the HIV category. ... Gilead has just reported the results of four phase III trials of its three-drug combo of new integrase inhibitor

Finalists 2017

for Novartis Pharma AG. Going Beyond Undetectable. by dna Communications. for Gilead.

Gilead plans fightback against HIV arch-rival ViiV

Gilead plans fightback against HIV arch-rival ViiV Gilead plans fightback against HIV arch-rival ViiV. Descovy sees phase III success after the TAF-based drug proves non-inferior to Triumeq. ... Gilead has reported the results of four phase III trials of a new HIV combination therapy pairing its Descovy

Bayer's lymphoma drug copanlisib gets speedy FDA review

Bayer's lymphoma drug copanlisib gets speedy FDA review Bayer is in pursuit of Gilead Sciences' P13K inhibitor Zydelig (idelalisib), which is already approved for FL and chronic lymphocytic leukaemia (CLL) in the US but hasn't lived up to ... First launched in 2014, Zydelig brought in $168m for Gilead over

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical

Porterhouse Medical provides medical and scientific communication services to the pharmaceutical industry across the globe, with a focus on programmes...

Latest intelligence

The new pharma marketing playbook
Learn about the 5 areas that must be in your pharma marketing playbook...
Pharma needs to evolve from customer-centricity to stakeholder-centricity
Customer-centricity and patient-centricity is no longer enough for pharma sales and marketing strategies as digital promises better customer experiences for all pharma stakeholders....
5 health behavioural factors to incorporate in your marketing
Achieve real health behaviour change by including these elements in your pharmaceutical marketing....

Infographics